250 related articles for article (PubMed ID: 20664196)
1. Efficacy and safety of micafungin as an empirical antifungal agent for febrile neutropenic patients with hematological diseases.
Park JS; Kim DH; Choi CW; Jeong SH; Choi JH; Kim K; Kim SJ; Jung CW; Yang DH; Jang JH
Acta Haematol; 2010; 124(2):92-7. PubMed ID: 20664196
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies.
Goto N; Hara T; Tsurumi H; Ogawa K; Kitagawa J; Kanemura N; Kasahara S; Yamada T; Shimizu M; Nakamura M; Matsuura K; Moriwaki H
Am J Hematol; 2010 Nov; 85(11):872-6. PubMed ID: 20882524
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
6. Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.
Cornely OA; Pappas PG; Young JA; Maddison P; Ullmann AJ
Expert Opin Drug Saf; 2011 Mar; 10(2):171-83. PubMed ID: 21306282
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.
Yoshida M; Tamura K; Imamura M; Niitsu Y; Sasaki T; Urabe A; Ohyashiki K; Naoe T; Kanamaru A; Tanimoto M; Masaoka T
Ann Hematol; 2012 Mar; 91(3):449-57. PubMed ID: 21894476
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
[TBL] [Abstract][Full Text] [Related]
9. Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia.
Yanada M; Kiyoi H; Murata M; Suzuki M; Iwai M; Yokozawa T; Baba H; Emi N; Naoe T
Intern Med; 2006; 45(5):259-64. PubMed ID: 16595990
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
[TBL] [Abstract][Full Text] [Related]
11. Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study.
Mizuno H; Sawa M; Yanada M; Shirahata M; Watanabe M; Kato T; Nagai H; Ozawa Y; Morishita T; Tsuzuki M; Goto E; Tsujimura A; Suzuki R; Atsuta Y; Emi N; Naoe T
Int J Hematol; 2013 Aug; 98(2):231-6. PubMed ID: 23857638
[TBL] [Abstract][Full Text] [Related]
12. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
13. Safety of micafungin in pediatric clinical trials.
Arrieta AC; Maddison P; Groll AH
Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies.
Toubai T; Tanaka J; Ota S; Shigematsu A; Shono Y; Ibata M; Hashino S; Kondo T; Kakinoki Y; Masauzi N; Kasai M; Iwasaki H; Kurosawa M; Asaka M; Imamura M
Intern Med; 2007; 46(1):3-9. PubMed ID: 17202726
[TBL] [Abstract][Full Text] [Related]
15. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
16. Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.
Venton G; Adam H; Colle J; Labiad Y; Mercier C; Ivanov V; Suchon P; Fanciullino R; Farnault L; Costello R
Med Mal Infect; 2016 Jun; 46(4):226-9. PubMed ID: 27126350
[TBL] [Abstract][Full Text] [Related]
17. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
[TBL] [Abstract][Full Text] [Related]
18. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
19. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
20. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
